跳至主要内容
临床试验/NCT03088163
NCT03088163Unknown不适用

The Value of DWI-MRI(Diffusion-weighted Imaging) in Evaluating the Early Efficacy of Liver Metastasis in Colorectal Cancer

Fudan University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2016年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
100
试验地点
1
主要终点
Response rate

研究概览

简要总结

The study is designed to evaluate the value of DWI-MRI (Diffusion weighted magnetic resonance imaging) in predicting the efficacy of liver metastases after chemotherapy in colorectal cancer.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •aged ≥18 years with histologically or cytologically confirmed advanced colorectal adenocarcinoma
  • •Eastern Cooperative Oncology Group performance status of 0 to 2
  • •life expectancy of ≥ 3 months
  • •at least one measurable liver metastatic lesion in MRI (≥10mm)
  • •have adequate bone marrow, hepatic, and renal function
  • •previously received no palliative chemotherapy

排除标准

  • •patients with previous chronic inflammatory bowel disease, chronic diarrhea or recurrent bowel obstruction
  • •patients with symptomatic brain metastases
  • •active clinical severe infection
  • •have contraindication of MRI screening

研究组 & 干预措施

DWI-MRI

Experimental

干预措施: Diffusion weighted magnetic resonance imaging (Device)

结局指标

主要结局

Response rate

时间窗: 2 months

the response rate predicted by DWI-MRI

次要结局

  • Progression free survival(2 months)
  • Overall survival(2 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Weijian Guo

Fudan University Shanghai Cancer Center

Fudan University

研究点 (1)

Loading locations...

相似试验